Tuesday, February 23, 2010

Big News! Cayston Approved

U.S. Food and Drug Administration Approves Cayston(R) (Aztreonam for Inhalation Solution) for the Improvement of Respiratory Symptoms in Cystic Fibrosis Patients with Pseudomonas Aeruginosa)

Link: CF Foundation Plays Important Role in Bringing New Inhaled Antibiotic Cayston to Patients
blog comments powered by Disqus